AI

Arteris, Inc.

AIPTechnologyNASDAQ

Semiconductors

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$70.6M
+22.3% YoY
Net Income
-$34.7M
-3.3% YoY
EBITDA
-$26.9M
-8.3% YoY
Free Cash Flow
$20.4M

Scan Results

Daily timeframe
DateIndicatorDetails
Jul 8 MACD Negative CrossoverHistogram -1.5394, negative momentum
Jul 7 MACD Negative CrossoverHistogram -1.0464, negative momentum
About Arteris, Inc.

Arteris, Inc., together with its subsidiaries, provides semiconductor system intellectual property (IP) solutions in the United States, rest of the Americas, China, Korea, the rest of the Asia. At a $1.43B market cap, Arteris, Inc. ranks as a small-cap company within technology. It manages on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets.

Key stats
Market Cap$1.43B
Fwd P/E197.08
EPS$-0.79
Beta1.92
52W Change+216.1%
Analysis

The balance sheet looks solid with $38.1M in cash comfortably exceeding the $6.7M debt load. A net cash position generally provides financial flexibility during uncertain economic periods. The company generates $20.4M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Revenue has grown from $50.4M (2022) to $70.6M (2025), reflecting a 40% increase over the period.

Arteris, Inc.'s elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. With cash comfortably exceeding debt, AIP has financial flexibility that may help navigate uncertain periods. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Arteris, Inc. and its sector.

Links
More Technology stocks
Browse all stocks →
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms